Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001847837-21-000001
Filing Date
2021-03-03
Accepted
2021-03-03 15:26:35
Documents
1
Effectiveness Date
2021-03-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6463
  Complete submission text file 0001847837-21-000001.txt   7525
Mailing Address 3139 W HOLCOMBE BLVD SUITE 445 HOUSTON TX 77025
Business Address 3139 W HOLCOMBE BLVD SUITE 445 HOUSTON TX 77025 617-921-9645
Asylia Therapeutics, Inc. (Filer) CIK: 0001847837 (see all company filings)

EIN.: 842626885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-391131 | Film No.: 21708685